online exam forum

Monday, February 14, 2011

Velaglucerase alfa (appoved by FDA) in 2010

Velaglucerase alfa:
 Gaucher disease, caused by deficiency of the enzyme glucocerebrosidase, results in accumulation of a toxic glycolipid substrate, called glucocerebroside. Velaglucerase alfa supplements or replaces beta-glucocerebrosidase, the enzyme that catalyzes the hydrolysis of glucocerebroside, reducing the amount of accumulated glucocerebroside and correcting the pathophysiology of Gaucher disease.

No comments:

Post a Comment